• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以中药靶向肿瘤微环境中的脂质重编程作为一种潜在的癌症治疗方法。

Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.

作者信息

Zuo Qian, Wu Yingchao, Hu Yuyu, Shao Cui, Liang Yuqi, Chen Liushan, Guo Qianqian, Huang Ping, Chen Qianjun

机构信息

State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

出版信息

Heliyon. 2024 May 7;10(9):e30807. doi: 10.1016/j.heliyon.2024.e30807. eCollection 2024 May 15.

DOI:10.1016/j.heliyon.2024.e30807
PMID:38765144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11101863/
Abstract

In the last ten years, there has been a notable rise in the study of metabolic abnormalities in cancer cells. However, compared to glucose or glutamine metabolism, less attention has been paid to the importance of lipid metabolism in tumorigenesis. Recent developments in lipidomics technologies have allowed for detailed analysis of lipid profiles within cancer cells and other cellular players present within the tumor microenvironment (TME). Traditional Chinese medicine (TCM) and its bioactive components have a long history of use in cancer treatments and are also being studied for their potential role in regulating metabolic reprogramming within TME. This review focuses on four core abnormalities altered by lipid reprogramming in cancer cells: de novo synthesis and exogenous uptake of fatty acids (FAs), upregulated fatty acid oxidation (FAO), cholesterol accumulation, which offer benefits for tumor growth and metastasis. The review also discusses how altered lipid metabolism impacts infiltrating immune cell function and phenotype as these interactions between cancer-stromal become more pronounced during tumor progression. Finally, recent literature is highlighted regarding how cancer cells can be metabolically reprogrammed by specific Chinese herbal components with potential therapeutic benefits related to lipid metabolic and signaling pathways.

摘要

在过去十年中,癌细胞代谢异常的研究显著增加。然而,与葡萄糖或谷氨酰胺代谢相比,脂质代谢在肿瘤发生中的重要性受到的关注较少。脂质组学技术的最新进展使得对癌细胞内以及肿瘤微环境(TME)中其他细胞成分的脂质谱进行详细分析成为可能。中药及其生物活性成分在癌症治疗中的应用历史悠久,目前也正在研究它们在调节TME内代谢重编程方面的潜在作用。本综述重点关注癌细胞中脂质重编程改变的四个核心异常:脂肪酸(FAs)的从头合成和外源性摄取、脂肪酸氧化(FAO)上调、胆固醇积累,这些异常为肿瘤生长和转移提供了有利条件。综述还讨论了脂质代谢改变如何影响浸润免疫细胞的功能和表型,因为在肿瘤进展过程中,癌症-基质之间的这些相互作用变得更加明显。最后,强调了最近的文献,即癌细胞如何通过特定的中药成分进行代谢重编程,这些成分在脂质代谢和信号通路方面具有潜在的治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/30992a0c8783/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/5bdcfc78fee4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/06b70c4eec95/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/30992a0c8783/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/5bdcfc78fee4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/06b70c4eec95/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cf/11101863/30992a0c8783/gr3.jpg

相似文献

1
Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.以中药靶向肿瘤微环境中的脂质重编程作为一种潜在的癌症治疗方法。
Heliyon. 2024 May 7;10(9):e30807. doi: 10.1016/j.heliyon.2024.e30807. eCollection 2024 May 15.
2
The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention.代谢重编程在癌症转移中的作用及中药干预的潜在机制。
Biomed Pharmacother. 2022 Sep;153:113376. doi: 10.1016/j.biopha.2022.113376. Epub 2022 Jul 12.
3
Role of lipid metabolism in hepatocellular carcinoma.脂质代谢在肝细胞癌中的作用。
Discov Oncol. 2024 Jun 4;15(1):206. doi: 10.1007/s12672-024-01069-y.
4
Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.针对免疫细胞对肿瘤微环境应激的脂质代谢重编程:一种潜在的肿瘤治疗方法。
Front Immunol. 2022 Sep 5;13:937406. doi: 10.3389/fimmu.2022.937406. eCollection 2022.
5
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat.肿瘤学中的脂质代谢:为何重要、如何研究以及如何治疗。
Cancers (Basel). 2021 Jan 26;13(3):474. doi: 10.3390/cancers13030474.
6
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.肿瘤微环境中癌症相关成纤维细胞和免疫细胞的代谢重编程及串扰。
Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022.
7
Lipids in the tumor microenvironment: From cancer progression to treatment.肿瘤微环境中的脂质:从癌症进展到治疗。
Prog Lipid Res. 2020 Nov;80:101055. doi: 10.1016/j.plipres.2020.101055. Epub 2020 Aug 11.
8
Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.靶向肿瘤免疫抑制微环境预防肝癌:中药在靶向递送上的应用。
Curr Top Med Chem. 2020;20(30):2789-2800. doi: 10.2174/1568026620666201019111524.
9
Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine.葡萄糖代谢与癌症的相关性及中医药干预
Evid Based Complement Alternat Med. 2022 Oct 14;2022:2192654. doi: 10.1155/2022/2192654. eCollection 2022.
10
Targeting dysregulated lipid metabolism in the tumor microenvironment.靶向肿瘤微环境中失调的脂质代谢。
Arch Pharm Res. 2023 Dec;46(11-12):855-881. doi: 10.1007/s12272-023-01473-y. Epub 2023 Dec 7.

引用本文的文献

1
Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.4-甲基伞形酮对雄黄-黄连中FAS和HAS2/3的双重抑制揭示了肝癌治疗的代谢检查点。
Nat Prod Bioprospect. 2025 Aug 21;15(1):56. doi: 10.1007/s13659-025-00540-9.

本文引用的文献

1
Unraveling the impact of melatonin treatment: Oxidative stress, metabolic responses, and morphological changes in HuH7.5 hepatocellular carcinoma cells.解析褪黑素治疗的影响:氧化应激、代谢反应和 HuH7.5 肝癌细胞的形态变化。
Pathol Res Pract. 2024 Jan;253:155056. doi: 10.1016/j.prp.2023.155056. Epub 2023 Dec 21.
2
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy.免疫检查点在抗肿瘤反应中的作用:一种潜在的抗肿瘤免疫疗法。
Front Immunol. 2023 Dec 15;14:1298571. doi: 10.3389/fimmu.2023.1298571. eCollection 2023.
3
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
FABP5 可在前列腺癌细胞的恶性进展中替代雄激素受体。
Int J Oncol. 2024 Feb;64(2). doi: 10.3892/ijo.2023.5606. Epub 2023 Dec 22.
4
Sanhuang Xiexin Decoction Ameliorates TNBC By Modulating JAK2-STAT3 and Lipid Metabolism.三黄泻心汤通过调节 JAK2-STAT3 和脂代谢改善三阴性乳腺癌。
Chin J Integr Med. 2024 Dec;30(12):1080-1089. doi: 10.1007/s11655-023-3555-x. Epub 2023 Nov 6.
5
Therapeutic Effects of Curcumin Derivatives against Obesity and Associated Metabolic Complications: A Review of In Vitro and In Vivo Studies.姜黄素衍生物防治肥胖及其相关代谢并发症的治疗作用:体外和体内研究综述。
Int J Mol Sci. 2023 Sep 21;24(18):14366. doi: 10.3390/ijms241814366.
6
Association between abnormal lipid metabolism and tumor.脂代谢异常与肿瘤的关系。
Front Endocrinol (Lausanne). 2023 May 25;14:1134154. doi: 10.3389/fendo.2023.1134154. eCollection 2023.
7
Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment.植物药对改善高血压肾病症状的影响:真实世界数据、回顾性队列、网络及实验评估分析
Front Pharmacol. 2023 Apr 4;14:1126972. doi: 10.3389/fphar.2023.1126972. eCollection 2023.
8
The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.中药作为2型糖尿病合并颈动脉粥样硬化患者辅助治疗的疗效和安全性:27项随机对照试验的更新荟萃分析。
Front Pharmacol. 2023 Mar 23;14:1091718. doi: 10.3389/fphar.2023.1091718. eCollection 2023.
9
Huangqin Decoction ameliorates ulcerative colitis by regulating fatty acid metabolism to mediate macrophage polarization via activating FFAR4-AMPK-PPARα pathway.黄芩汤通过激活FFAR4-AMPK-PPARα通路调节脂肪酸代谢以介导巨噬细胞极化,从而改善溃疡性结肠炎。
J Ethnopharmacol. 2023 Jul 15;311:116430. doi: 10.1016/j.jep.2023.116430. Epub 2023 Mar 28.
10
Role of CD36 in cancer progression, stemness, and targeting.CD36在癌症进展、干性及靶向治疗中的作用
Front Cell Dev Biol. 2022 Dec 8;10:1079076. doi: 10.3389/fcell.2022.1079076. eCollection 2022.